Study guide

15.2 Pelvic Organ Prolapse & Urinary Incontinence

AMCB Certified Nurse-Midwife CNM

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Early Pregnancy — Diagnosis, History, Dating & Models of Care

1.1 Signs of Pregnancy, hCG Kinetics & Acceptance of Pregnancy 1.2 Prenatal History, Obstetric Notation & Gestational Dating 1.3 The Initial Prenatal Laboratory Panel 1.4 Prenatal Genetic Screening, Diagnostic Testing & Hereditary Risk 1.5 Models of Prenatal Care, Birth-Setting Counseling & Community Referral

2 Chapter 2: Ongoing Prenatal Assessment, Nutrition & Common Discomforts

2.1 Prenatal Visit Cadence, Milestone Screening & Fundal Height 2.2 Leopold Maneuvers, Fetal Heart Auscultation & Antepartum Surveillance 2.3 Clinical Pelvimetry & Assessment of the Bony Pelvis 2.4 Maternal Nutrition, Weight Gain & Immunization in Pregnancy 2.5 Nausea, Vomiting & Gastrointestinal Discomforts of Pregnancy 2.6 Musculoskeletal, Vascular & Neurologic Discomforts of Pregnancy

3 Chapter 3: Hypertensive, Endocrine & Hematologic Complications of Pregnancy

3.1 Classification & Diagnosis of Hypertensive Disorders of Pregnancy 3.2 Acute Severe Hypertension, Magnesium Sulfate & Eclampsia 3.3 Delivery Timing, Aspirin Prophylaxis & Postpartum Hypertension 3.4 Gestational Diabetes: Pathophysiology, Screening & Diagnosis 3.5 Glycemic Management, Fetal Surveillance & Delivery Timing in Gestational Diabetes 3.6 Thyroid Disorders & Anemia in Pregnancy

4 Chapter 4: Bleeding, Amniotic Fluid Disorders, Preterm Birth & Perinatal Loss

4.1 First-Trimester Bleeding, Early Pregnancy Loss & Gestational Trophoblastic Disease 4.2 Ectopic Pregnancy: Diagnosis & Management 4.3 Third-Trimester Bleeding & Amniotic Fluid Volume Disorders 4.4 Preterm Labor & Preterm Prelabor Rupture of Membranes 4.5 Intrauterine Fetal Demise, Stillbirth & Bereavement Care

5 Chapter 5: Normal Labor, Birth & Intrapartum Fetal Surveillance

5.1 Onset of Labor, True Versus False Labor & Nutrition in Labor 5.2 The First and Second Stages of Labor 5.3 Cardinal Movements, Third & Fourth Stages of Labor 5.4 Cord Clamping, Cord Blood, Cord Gases & Placental Examination 5.5 Fetal Oxygenation, Intermittent Auscultation & Uterine Activity Monitoring 5.6 Electronic Fetal Monitoring Parameters & the NICHD Categories 5.7 Intrauterine Resuscitation, Scalp Electrode & Amnioinfusion

6 Chapter 6: Labor Support, Analgesia, Induction & Augmentation

6.1 The Midwifery Model, Continuous Labor Support & Non-Pharmacologic Comfort 6.2 Water Immersion, Waterbirth & Non-Supine Birth Positions 6.3 Systemic, Neuraxial & Regional Analgesia in Labor 6.4 Indications & Timing for Induction of Labor 6.5 The Bishop Score & Cervical Ripening Methods 6.6 Oxytocin Titration, Tachysystole Management & Amniotomy

7 Chapter 7: Intrapartum Emergencies, Malpresentation & Perineal Repair

7.1 Shoulder Dystocia: Recognition & the HELPERR Protocol 7.2 Dystocia Complications, Umbilical Cord Prolapse & Intraamniotic Infection 7.3 Malposition, Manual Rotation, Breech, Face Presentation & Nuchal Cord 7.4 Perineal Anatomy & Classification of Obstetric Lacerations 7.5 Episiotomy & Surgical Perineal Repair 7.6 TOLAC, VBAC & Uterine Rupture

8 Chapter 8: The Normal Puerperium, Postpartum Assessment & Lactation

8.1 Puerperal Physiology, Uterine Involution & Lochia 8.2 The BUBBLE-HE Postpartum Assessment 8.3 Bladder, Bowel & Perineal Care and the Postpartum Care Continuum 8.4 Lactation Neuroendocrinology & the Stages of Lactogenesis 8.5 LATCH Assessment, Latch Biomechanics & Adequate Intake 8.6 Lactation Complications, Medication Safety & Contraindications

9 Chapter 9: Postpartum Contraception, Family Planning & Hemorrhage

9.1 Return of Fertility, Lactational Amenorrhea & US MEC in the Puerperium 9.2 Postpartum Hormonal Contraception & Intrauterine Devices 9.3 Barrier & Permanent Contraception, Postpartum Sexuality & Family Support 9.4 Postpartum Hemorrhage: Definition, Shock Recognition & Quantitative Blood Loss 9.5 The Four Ts: Etiology of Postpartum Hemorrhage 9.6 Hemorrhage Resuscitation, Uterotonics, TXA & Surgical Escalation

10 Chapter 10: Puerperal Infection, Thromboembolism, Cesarean Recovery & Perinatal Mental Health

10.1 Puerperal Endometritis & Septic Pelvic Thrombophlebitis 10.2 Puerperal Wound Infection, Mastitis & Breast Abscess 10.3 Postpartum Venous Thromboembolism 10.4 Post-Cesarean Recovery: Inpatient Care & Care After Discharge 10.5 Postpartum Blues, Depression & EPDS Screening 10.6 Treating Postpartum Depression, Anxiety, OCD & Psychosis

11 Chapter 11: Neonatal Transition, Resuscitation & the Newborn Examination

11.1 Fetal-to-Neonatal Transition & Circulatory Remodeling 11.2 APGAR Scoring & the NRP Initial Steps 11.3 Positive Pressure Ventilation, MR. SOPA & Advanced Resuscitation 11.4 Newborn Vital Signs, Anthropometrics & the Ballard Score 11.5 Cranial Assessment & Head-to-Chest Examination 11.6 Genitourinary & Musculoskeletal Examination and Primitive Reflexes

12 Chapter 12: Newborn Prophylaxis, Screening, Common Disorders & Care Through 28 Days

12.1 Standard Neonatal Prophylaxis: Vitamin K, Eye Ointment & Hepatitis B 12.2 Universal Newborn Screening: Hearing, CCHD & Dried Blood Spot 12.3 Neonatal Hypoglycemia, Thermoregulation & the Infant of a Diabetic Mother 12.4 Neonatal Hyperbilirubinemia & Phototherapy 12.5 Infant Feeding Education, Circumcision Counseling & Care Through 28 Days

13 Chapter 13: Well-Woman Preventive Care, Cancer Screening & Immunization

13.1 The Well-Woman Visit & Cervical Cancer Screening 13.2 ASCCP Risk-Based Management & Breast Cancer Screening 13.3 Colorectal Cancer & Osteoporosis Screening 13.4 Adult Immunization & Environmental and Occupational Exposure Screening

14 Chapter 14: Contraception, Abortion Care & Fertility Evaluation

14.1 Contraceptive Efficacy Tiers & Long-Acting Reversible Contraception 14.2 Combined Hormonal Contraception 14.3 Progestin-Only Methods & Emergency Contraception 14.4 Abortion Care: Options Counseling, Medication Abortion & Follow-Up 14.5 Initial Infertility Evaluation & Gynecologic Imaging Referral

15 Chapter 15: Benign Gynecologic Conditions, Pelvic Floor & Menstrual Disorders

15.1 Endometriosis & Adenomyosis 15.2 Pelvic Organ Prolapse & Urinary Incontinence 15.3 Adnexal Masses, Malignancy Red Flags & Vulvar Disease 15.4 The Normal Menstrual Cycle & Anticipatory Guidance 15.5 The FIGO PALM-COEIN Classification of Abnormal Uterine Bleeding 15.6 Evaluating Abnormal Uterine Bleeding & the Amenorrhea Workup 15.7 Polycystic Ovary Syndrome

16 Chapter 16: Vaginitis, Sexually Transmitted Infections, Sexual Health & Menopause

16.1 Differential Diagnosis of Vaginitis & Bacterial Vaginosis 16.2 Candidiasis, Trichomoniasis, Chlamydia & Gonorrhea 16.3 Pelvic Inflammatory Disease 16.4 Genital Herpes, Syphilis & Anogenital Warts 16.5 Sexual Health Assessment, Sexual Function & Care After Sexual Assault 16.6 Reproductive Aging, Menopause Definitions & Clinical Manifestations 16.7 Menopausal Hormone Therapy 16.8 Non-Hormonal Therapies & Postmenopausal Osteoporosis

17 Chapter 17: Primary Care — Chronic Disease & Common Acute Conditions

17.1 Midwifery Primary Care Scope & Hypertension Management 17.2 Antihypertensive Pharmacotherapy & Hyperlipidemia 17.3 Type 2 Diabetes & Thyroid Disease in Primary Care 17.4 Respiratory Infections, Asthma & Urinary Tract Infection 17.5 Gastrointestinal & Dermatologic Conditions 17.6 Mental Health Screening & Substance Use Disorders 17.7 Intimate Partner Violence, Reproductive Coercion & Human Trafficking

18 Chapter 18: Midwifery Scope of Practice, Ethics, Collaboration & Health Equity

18.1 Regulatory Foundation of Practice & the Midwifery Model of Care 18.2 Bioethics, Informed Refusal & Collaborative Practice 18.3 Maternal Health Disparities, Structural Racism & Inclusive Care

15.2 Pelvic Organ Prolapse & Urinary Incontinence

Key Takeaways Explain This Topic AI

Cystocele is the most common prolapse, and digital splinting to achieve complete defecation is the hallmark symptom of a significant rectocele.

Stress incontinence leaks small volumes synchronously with coughing or exertion and has a normal post-void residual under 50 mL.

Urgency incontinence follows a sudden compelling urge with moderate to large volume loss, daytime frequency above 8 voids, and nocturia of 2 or more.

Overflow incontinence produces continuous dribbling with a markedly elevated post-void residual above 200 to 300 mL and requires bladder decompression.

Pelvic floor muscle training is first-line for stress incontinence, while behavioral therapy with timed voiding and bladder retraining is first-line for urgency incontinence.

Last updated: September 2026

Pelvic Organ Prolapse (POP): Anatomy, Staging & Non-Surgical Care

Pelvic organ prolapse is the downward herniation or descent of the pelvic viscera (bladder, uterus, vaginal cuff, bowel, rectum) into or through the vaginal canal, resulting from attenuation or damage to the pelvic floor muscular diaphragm (levator ani muscle complex) and endopelvic connective tissue supports (uterosacral-cardinal ligament complex and pubocervical/rectovaginal fascia).

Compartmental Classification

Anterior Compartment: Cystocele (herniation of the anterior vaginal wall allowing bladder descent) and urethrocele (urethral hypermobility). Most common type of prolapse.

Apical Compartment: Uterine prolapse (herniation of the cervix and uterus down the vaginal axis) or vaginal vault prolapse (descent of the vaginal apex following prior total hysterectomy).

Posterior Compartment: Rectocele (herniation of the rectovaginal septum and posterior vaginal wall allowing the rectum to bulge into the vagina) and enterocele (herniation of the peritoneal sac of the pouch of Douglas, containing loops of small intestine, dissecting between the anterior rectal and posterior vaginal walls).

Hallmark Symptom of Rectocele — Digital Splinting: Patients with a moderate-to-severe rectocele characteristically report obstructed defecation and tenesmus, requiring them to insert a finger into the vagina or press on the perineal body ( digital splinting ) to manually reduce the bulge and achieve complete evacuation of stool.

Staging Systems: Baden-Walker vs. POP-Q

Baden-Walker Halfway System: Clinically intuitive 0 to 4 grading system based on maximal protrusion relative to the hymenal ring: Grade 0 (normal position), Grade 1 (descent halfway to hymen), Grade 2 (descent to hymen), Grade 3 (descent halfway past hymen), Grade 4 (complete procidentia / maximum descent).

POP-Q (Pelvic Organ Prolapse Quantification) System: The international standard objective staging system that measures 9 specific anatomical points relative to the hymenal plane (expressed in centimeters, where proximal/inside points are negative numbers, the hymen is 0, and distal/protruding points are positive numbers):

Stage 0: No prolapse demonstrated (points Aa, Ap, Ba, Bp at -3 cm; C between -tvl and -(tvl - 2)).

Stage I: Most distal portion of the prolapse is >1 cm above the level of the hymen (less than -1 cm).

Stage II: Most distal portion is between 1 cm above and 1 cm below the hymen (-1 cm to +1 cm).

Stage III: Most distal portion extends >1 cm below the hymen , but protrudes no further than 2 cm less than the total vaginal length (tvl).

Stage IV: Complete procidentia / eversion of the total length of the lower genital tract (protrusion ≥ tvl - 2 cm).

Non-Surgical Midwifery Management of POP

Pelvic Floor Muscle Training (PFPT / Kegel Exercises): First-line therapy for symptomatic Stage I and II prolapse. Structured contraction and relaxation of the pubococcygeus and levator ani musculature increases pelvic floor muscle tone, endurance, and structural support, preventing progression and alleviating dragging pelvic pressure.

Pessary Fitting & Management: Silicone mechanical support devices inserted into the upper vagina to reposition prolapsed organs.

Support Pessaries (Ring with Support, Shaatz): First-line for mild to moderate prolapse and cystoceles. Highly flexible; patients can easily learn to remove, clean, and reinsert them independently at home.

Space-Occupying Pessaries (Gellhorn, Cube): Indicated for severe prolapse (Stage III and IV procidentia) or when a deficient perineal body cannot retain a ring pessary. Gellhorn pessaries are stiffer with a central stem; typically removed and re-evaluated by the clinician every 2 to 3 months.

Fitting Procedure: Select the largest size pessary that comfortably relieves prolapse symptoms without causing discomfort. Confirm proper fit by having the patient walk, bend, cough, and void in the clinic without expulsion.

Topical Vaginal Estrogen Therapy: In postmenopausal women with hypoestrogenic vaginal mucosal atrophy, co-prescribing topical vaginal estrogen cream (17β-estradiol 0.01% cream 0.5 to 1 g, or estradiol 10 mcg vaginal tablets) 2 to 3 times weekly restores vaginal epithelial glycogenation, thickens the mucosa, enhances submucosal vascularity, and prevents or treats mucosal ulcerations caused by pessary friction.

Urinary Incontinence: Differential Diagnosis & Evidence-Based Interventions

Urinary incontinence—the involuntary loss of urine—afflicts over 50% of adult women. Accurate clinical classification into stress, urgency, mixed, or overflow subtypes dictates appropriate management.

Assessment Parameter Stress Urinary Incontinence (SUI) Urgency Urinary Incontinence (UUI / OAB) Overflow Incontinence

Underlying Etiology Urethral Hypermobility (loss of pubocervical fascial support) OR Intrinsic Sphincter Deficiency Detrusor Muscle Overactivity (involuntary, uninhibited detrusor contractions during bladder filling) Impaired Detrusor Contractility (neurogenic) OR Bladder Outlet Obstruction (severe POP)

Triggering Events Involuntary loss synchronous with coughing, sneezing, laughing, lifting, or exercising Involuntary loss preceded by a sudden, compelling, uncontrollable urge to void Constant involuntary dribbling, hesitancy, weak stream, sense of incomplete emptying

Volume of Leakage Small spurts or drops coincident with physical exertion Moderate to large volume; complete bladder emptying Continuous small-volume dribbling

Nocturia & Frequency Typically absent or minimal Daytime frequency (>8 voids/day) and Nocturia (≥2 voids/night) Frequent small voids, nocturnal enuresis

Post-Void Residual (PVR) Normal (<50 mL) Normal (<50 mL) Markedly Elevated (>200 to 300 mL)

First-Line Midwifery Management Pelvic floor muscle training (Kegel exercises) , continence pessary (ring with knob) Behavioral therapy (timed voiding, bladder retraining, eliminate caffeine/irritants) Decompress bladder via clean intermittent self-catheterization (CIC) ; treat obstruction

Second-Line Pharmacotherapy None approved (Surgical gold standard: Midurethral synthetic sling ) Antimuscarinics (Oxybutynin) OR Beta-3 Agonists (Mirabegron, Vibegron) Treat cause. Anticholinergics are STRICTLY CONTRAINDICATED (worsen retention).

Pharmacologic Nuances in Urgency Incontinence

Antimuscarinic / Anticholinergic Agents (Oxybutynin, Tolterodine, Solifenacin): Block postganglionic muscarinic (M2 and M3) receptors on detrusor smooth muscle, inhibiting uninhibited contractions. Significant systemic anticholinergic adverse effects: dry mouth (xerostomia), severe constipation, blurred vision, tachycardia , and risk of cognitive impairment/dementia in elderly patients. Contraindicated in uncontrolled narrow-angle glaucoma and gastric retention.

Beta-3 Adrenergic Receptor Agonists (Mirabegron, Vibegron): Stimulate beta-3 adrenergic receptors in the detrusor, promoting detrusor smooth muscle relaxation during the bladder filling phase, increasing bladder storage capacity. Free of anticholinergic side effects ; does not cause dry mouth, constipation, or cognitive deficits. Clinical Precaution: Can cause dose-dependent elevations in blood pressure; contraindicated in severe, uncontrolled hypertension (SBP ≥180 or DBP ≥110 mmHg).